Abstract
The antiherpes drug acyclovir was found to inhibit HIV following its phosphorylation by human herpesviruses, providing a hypothesis to explain the observed beneficial effects of acyclovir therapy on HIV viral load and HIV disease progression. This report underscores the importance of studying HIV in the context of microbial copathogens.
MeSH terms
-
Acyclovir / metabolism
-
Acyclovir / pharmacology*
-
Anti-HIV Agents / metabolism
-
Anti-HIV Agents / pharmacology*
-
HIV Infections / complications
-
HIV Infections / drug therapy*
-
HIV-1 / drug effects*
-
Herpes Simplex / complications
-
Herpes Simplex / virology*
-
Herpesvirus 2, Human / metabolism*
-
Humans
-
Phosphorylation
-
Prodrugs / metabolism
-
Prodrugs / pharmacokinetics
Substances
-
Anti-HIV Agents
-
Prodrugs
-
Acyclovir